Condition

Open Angle Glaucoma (8)

Ocular Hypertension (5)

Angle Closure Glaucoma (1)

Glaucoma (1)

Narrow Angles (1)

Pigmentary Glaucoma (1)

Primary Open Angle Glaucoma (1)

Pseudoexfoliation Glaucoma in Both Eyes (1)

Pseudoexfoliation Syndrome (1)

Overall Status

Completed (7)

Withdrawn (1)

Phase

n/a (2)

phase 2 (2)

phase 3 (2)

Sponsor

Aerie Pharmaceuticals (2)

Wills Eye (2)

Agency for Healthcare Research and Quality (AHRQ) (1)

Hermann Eye Center (1)

Pfizer (1)

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)

Collaborator

Alcon Research (1)

American Academy of Ophthalmology (1)

Jules Stein Eye Institute (1)

Tanta Medical School, Tanta University (1)

Study Documents

Intervention Type

drug (5)

other (1)

procedure (1)

Funder Type

Industry (4)

Other (3)

U.S. Fed (1)

Study Type

Interventional (6)

Observational (1)

Observational [Patient Registry] (1)

Open Angle Glaucoma

Showing NaN - NaN of 8

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED